CompletedNot Applicable

Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM

United States1,247 participantsStarted 2012-02

Plain-language summary

Liver biopsy for the assessment of fibrosis has multiple limitations. Liver ShearWaveTM Elastography may provide a non-invasive, fast, and reproducible alternative for the quantitative assessment of liver fibrosis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Males and Females over the age of 18 * Patients of Liver Consultant's of Texas Dallas office, with chronic liver disease or liver transplant patient seen in Liver Transplant Clinic * Patients diagnosed with heart failure Exclusion Criteria: \- Any person unable to provide an informed consent

What they're measuring

Shearwave Elastography Ultrasound

Timeframe: 1 day

Trial details

NCT IDNCT02070315

SponsorBaylor Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-04-28

View on ClinicalTrials.gov More Liver Disease trials